$ACET 90 DAYS STOCK PRICE FORECAST
Stock Price
About the Company
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of 'off-the-shelf' gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
Similar Companies
| Name | Ticker | Market Capitalization (USD M) | Revenue (USD M) | Price/Book | Price/Earning | Net Margin (%) |
|---|---|---|---|---|---|---|
| Conversion Labs Inc | CVLB | 108548 | 35213 | 3.74 | 42.66 | 7.33 |
| Royalty Pharma plc | RPRX | 18925 | 2239 | 2.81 | 15.20 | 43.40 |
| Organon & Co. | OGN | 8844 | 7891 | -4.56 | 5.07 | 22.06 |
| Arvinas Inc | ARVN | 3725 | 21 | 7.48 | -22.56 | -782.93 |
| Tilray Inc | TLRY | 3241 | 564 | 1.08 | -8.14 | -66.49 |
| ATAI Life Sciences N.V. | ATAI | 2272 | 20 | 4.78 | -10.40 | -932.88 |
| Cronos Group Inc | CRON | 2097 | 57 | 1.32 | -14.52 | -258.59 |
| Usana Health Sciences Inc | USNA | 2079 | 1254 | 4.73 | 14.98 | 11.09 |
| NRX Pharmaceuticals Inc | NRXP | 1170 | 2321 | 0.45 | 5.05 | 9.91 |
| Phathom Pharmaceuticals Inc | PHAT | 964 | 6.54 | -6.01 | None | |
| Phibro Animal Health Corp. | PAHC | 893 | 833 | 3.70 | 16.25 | 6.53 |
| Intersect ENT Inc | XENT | 893 | 103 | 21.65 | -13.01 | -66.55 |
| Edgewise Therapeutics Inc | EWTX | 796 | 2.70 | -29.55 | None | |
| Fulcrum Therapeutics Inc | FULC | 711 | 15 | 8.62 | -9.63 | -481.07 |
| Pliant Therapeutics Inc | PLRX | 614 | 13 | 2.51 | -7.16 | -613.56 |
| Cyteir Therapeutics Inc | CYT | 596 | 3.20 | -20.62 | None | |
| Urovant Sciences Ltd | UROV | 503 | -3.65 | -3.08 | None | |
| Ikena Oncology Inc | IKNA | 404 | 10 | 2.18 | -7.38 | -551.28 |
| Chromadex Corp | CDXC | 394 | 62 | 9.92 | -16.62 | -37.51 |
| Provention Bio Inc | PRVB | 377 | 2.53 | -2.94 | None | |
| Rain Therapeutics Inc | RAIN | 355 | 413 | 2.19 | -11.66 | 123.20 |
| Verrica Pharmaceuticals Inc | VRCA | 325 | 12 | 6.57 | -8.92 | -301.45 |
| Evolus Inc | EOLS | 310 | 77 | 4.10 | -2.08 | -171.53 |
| Terns Pharmaceuticals Inc | TERN | 252 | 1.40 | -7.30 | None | |
| Adicet Bio Inc | ACET | 251 | 9 | 1.09 | -4.46 | -603.06 |
| Milestone Pharmaceuticals Inc | MIST | 219 | 15 | 1.23 | -7.37 | -215.93 |
| Kaleido Biosciences Inc | KLDO | 184 | 1 | 4.11 | -2.07 | None |
| Citius Pharmaceuticals Inc | CTXR | 179 | 2.24 | -7.81 | None | |
| scPharmaceuticals Inc | SCPH | 167 | 119 | 2.45 | -5.52 | -27.05 |
| Eyenovia Inc | EYEN | 143 | 6 | 16.29 | -7.31 | -324.94 |
| Aquestive Therapeutics Inc | AQST | 142 | 42 | -2.95 | -2.21 | -152.73 |
| LifeMD Inc | LFMD | 139 | 64 | -22.39 | -1.00 | -133.55 |
| Eton Pharmaceuticals Inc | ETON | 124 | 15 | 6.13 | -10.10 | -74.52 |
| Osmotica Pharmaceuticals Plc | OSMT | 122 | 190 | 2.37 | -1.31 | -47.85 |
| Kala Pharmaceuticals Inc | KALA | 119 | 11 | 1.53 | -0.94 | None |
| Xeris Biopharma Holdings Inc | XERS | 111 | 34 | 12.19 | -1.44 | -248.46 |
| Odonate Therapeutics Inc | ODT | 110 | 1.39 | -0.94 | None | |
| Anebulo Pharmaceuticals Inc | ANEB | 101 | 7.83 | -2.54 | None | |
| Opiant Pharmaceuticals Inc | OPNT | 100 | 37 | 3.03 | -96.15 | -3.06 |
| Aerpio Pharmaceuticals Inc | ARPO | 99 | 15 | 2.98 | -5.24 | -28.77 |
| Mannatech Inc | MTEX | 82 | 158 | 3.27 | 12.89 | 4.22 |
| Natural Alternatives Internati | NAII | 80 | 179 | 1.07 | 7.90 | 6.03 |
| India Globalization Capital In | IGC | 67 | 0 | 2.45 | -7.60 | -981.18 |
| VYNE Therapeutics Inc | VYNE | 51 | 16 | 0.77 | 2.31 | -554.66 |
| Shineco Inc | TYHT | 44 | 3 | 2.17 | -1.55 | -159.60 |
| Assertio Holdings Inc | ASRT | 36 | 117 | 0.49 | -0.63 | -38.05 |
| Dermata Therapeutics Inc | DRMA | 36 | -75.67 | -7.32 | None | |
| Acasti Pharma Inc | ACST | 33 | 0 | 1.43 | -1.66 | -611.47 |
| Nabriva Therapeutics Plc | NBRV | 29 | 12 | 0.88 | -0.49 | -452.55 |
| Lexaria Bioscience Corp | LEXX | 27 | 1 | 3.76 | -6.95 | -445.15 |
| Bio-Path Holdings Inc | BPTH | 26 | 0 | 1.19 | -2.49 | 18.96 |
| Reviva Pharmaceuticals Holding | RVPH | 25 | 1.41 | -4.08 | None | |
| Baudax Bio Inc | BXRX | 25 | 1 | -10.80 | 0.76 | 9.10 |
| Trevi Therapeutics Inc | TRVI | 23 | 1.64 | -0.66 | None | |
| Timber Pharmaceuticals Inc | TMBR | 20 | 0 | 8.75 | 0.67 | -527.55 |
| Hoth Therapeutics Inc | HOTH | 19 | 1.64 | -2.02 | None | |
| Cyanotech Corp. | CYAN | 17 | 34 | 0.99 | 13.57 | 3.83 |
| Sonoma Pharmaceuticals Inc. | SNOA | 11 | 17 | 3.32 | -2.16 | -31.96 |
Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer
It is my pleasure to announce Blake's promotion to Chief Scientific Officer. During his tenure, Blake's strong scientific acumen, leadership, and deep knowledge of cell therapies has led us to new ...
Adicet Bio Inc Ordinary Shares 1IJA
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Adicet Bio Promotes Blake Aftab to Scientific Chief
Adicet Bio Inc. said it has promoted Blake Aftab to chief scientific officer from vice president and head of research, positions he has held since April. Dr. Aftab was previously vice president ...
Adicet to Present Preclinical Data from Allogeneic Gamma Delta T Cell Platform at SITC 36th Annual Meeting
MENLO PARK, Calif. and BOSTON, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (NASDAQ:ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell ...
Adicet promotes head of research to chief scientific officer
Adicet Bio (NASDAQ:ACET) promoted Blake Aftab to the position of Senior Vice President and Chief Scientific Officer. Aftab has served as Vice President and Head of Research since April 2021.
Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer
MENLO PARK, Calif. and BOSTON, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell ...
Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer
MENLO PARK, Calif. and BOSTON, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell ...